Video · 1:03

FOXO4-DRI in Canada: The Peptide That “Reverses Aging”?

Kobi Williams · Popular Peptides Canada · 2026-10-02

FOXO4-DRI is a peptide built from mirror-image (D-) amino acids, designed to break the link between two proteins, FOXO4 and p53, that helps senescent cells survive. In a 2017 study in Cell, a Dutch team reported that it restored fur, fitness and kidney function in fast-aging mice, and improved kidney function in naturally old mice; a 2020 study in old mice reported better testosterone output. We found no published human trial of FOXO4-DRI, and it is not approved as a medicine anywhere.

Hype check · scorecard

FOXO4-DRI

Internet hype9/10

Human evidence0/10

Striking results in mice. No published human trials.

Scores = our read of the published studies, not medical advice.

See every compound on the Hype Leaderboard →

Get the next hype check first

One short email when a new video drops, plus updates to the Hype Leaderboard. No spam; unsubscribe anytime.

Full transcript

[0:00]“The peptide that reverses aging.” That’s how FOXO4-DRI gets sold online. So has it reversed aging in anyone? Let’s check.

[0:08]FOXO4-DRI is a peptide built from mirror-image amino acids. It targets senescent cells, the so-called zombie cells that stop dividing but refuse to die. It breaks a link between two proteins, FOXO4 and p53, that helps those cells survive.

[0:23]In 2017, a Dutch team published it in the journal Cell. In fast-aging mice, it brought back fur, fitness and kidney function. In normally old mice, kidney function improved. A 2020 study in old mice reported better testosterone output. That’s impressive mouse data.

[0:39]In people? We couldn’t find a single published human trial. Not one. The company set up to develop the idea is still at the lab stage.

[0:47]FOXO4-DRI isn’t approved as a medicine anywhere. So: real science, mice with thicker fur, and zero humans. Read the studies, not the anti-aging ads.